Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1973 Jun;26(6):393–395. doi: 10.1136/jcp.26.6.393

Bactericidal activity of metronidazole against Bacteroides fragilis

J P F Whelan 1,2, J H Hale 1,2
PMCID: PMC477766  PMID: 4718964

Abstract

Metronidazole was found to be active against Bacteroides fragilis strains isolated from human lesions. The minimal inhibitory concentrations (MIC) were from 0·16 to 2·5 μg/ml and the minimal bactericidal concentrations (MBC) were from 0·16 to 2·5 μg/ml; usually the MIC and MBC figures were equivalent. These levels are easily attainable in the serum following normal therapeutic doses. The drug is not toxic and side effects are rare and it would therefore seem highly suitable for treating Bacteroides infections and also may be considered prophylactically in certain situations that are described.

Full text

PDF
393

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Benazet F., Guillaume L. Induction of in-vivo resistance of trichomonas vaginalis to nitrimidazine. Lancet. 1971 Oct 30;2(7731):982–983. doi: 10.1016/s0140-6736(71)90309-6. [DOI] [PubMed] [Google Scholar]
  2. DUREL P., ROIRON V., SIBOULET A., BOREL L. J. Systemic treatment of human trichomoniasis with a derivative of nitro-imidazole, 8823 RP. Br J Vener Dis. 1960 Mar;36:21–26. doi: 10.1136/sti.36.1.21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. ELEK S. D., HILSON G. R. Combined agar diffusion and replica plating techniques in the study of antibacterial substances. J Clin Pathol. 1954 Feb;7(1):37–44. doi: 10.1136/jcp.7.1.37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Freeman W. A., McFadzean J. A., Whelan J. P. Activity of metronidazole against experimental tetanus and gas gangrene. J Appl Bacteriol. 1968 Dec;31(4):443–447. doi: 10.1111/j.1365-2672.1968.tb00393.x. [DOI] [PubMed] [Google Scholar]
  5. Füzi M., Csukás Z. Das antibakterielle Wirkungsspektrum des Metronidazols. Zentralbl Bakteriol Orig. 1970;213(2):258–262. [PubMed] [Google Scholar]
  6. GILLESPIE W. A., GUY J. Bacteroides in intra-abdominal sepsis: their sensitivity to antibiotics. Lancet. 1956 Jun 30;270(6931):1039–1041. doi: 10.1016/s0140-6736(56)90802-9. [DOI] [PubMed] [Google Scholar]
  7. Ingham H. R., Selkon J. B., Codd A. A., Hale J. H. A study in vitro of the sensitivity to antibiotics of Bacteroides fragilis. J Clin Pathol. 1968 Jul;21(4):432–436. doi: 10.1136/jcp.21.4.432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ingham H. R., Selkon J. B., Codd A. A., Hale J. H. The effect of carbon dioxide on the sensitivity of Bacteroides fragilis to certain antibiotics in vitro. J Clin Pathol. 1970 Apr;23(3):254–258. doi: 10.1136/jcp.23.3.254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. KANE P. O., McFADZEAN J. A., SQUIRES S., KING A. J., NICOL C. S. Absorption and excretion of metronidazole. I. Serum concentration and urinary excretion after oral administration. Br J Vener Dis. 1961 Dec;37:273–275. doi: 10.1136/sti.37.4.273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Keighley E. E. Trichomoniasis in a closed community: efficacy of metronidazole. Br Med J. 1971 Jan 23;1(5742):207–209. doi: 10.1136/bmj.1.5742.207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kislak J. W. The susceptibility of Bacteroides fragilis to 24 antibiotics. J Infect Dis. 1972 Mar;125(3):295–299. doi: 10.1093/infdis/125.3.295. [DOI] [PubMed] [Google Scholar]
  12. McFadzean J. A., Pugh I. M., Squires S. L., Whelan J. P. Further observations on strain sensitivity of Trichomonas vaginalis to metronidazole. Br J Vener Dis. 1969 Jun;45(2):161–162. doi: 10.1136/sti.45.2.161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Nastro L. J., Finegold S. M. Bactericidal activity of five antimicrobial agents against Bacteroides fragilis. J Infect Dis. 1972 Jul;126(1):104–107. doi: 10.1093/infdis/126.1.104. [DOI] [PubMed] [Google Scholar]
  14. Powell S. J., MacLeod I., Wilmot A. J., Elsdon-Dew R. Metronidazole in amoebic dysentery and amoebic liver abscess. Lancet. 1966 Dec 17;2(7477):1329–1331. doi: 10.1016/s0140-6736(66)92081-2. [DOI] [PubMed] [Google Scholar]
  15. Rotheram E. B., Jr, Schick S. F. Nonclostridial anaerobic bacteria in septic abortion. Am J Med. 1969 Jan;46(1):80–89. doi: 10.1016/0002-9343(69)90060-6. [DOI] [PubMed] [Google Scholar]
  16. SHINN D. L., SQUIRES S., MCFADZEAN J. A. THE TREATMENT OF VINCENT'S DISEASE WITH METRONIDAZOLE. Dent Pract Dent Rec. 1965 Apr;15:275–280. [PubMed] [Google Scholar]
  17. Tillotson J. R., Lerner A. M. Bacteroides pneumonias. Characteristics of cases with empyema. Ann Intern Med. 1968 Feb;68(2):308–317. doi: 10.7326/0003-4819-68-2-308. [DOI] [PubMed] [Google Scholar]
  18. Todd J. C. Wound infection: etiology, prevention, and management, including selection of antibiotics. Surg Clin North Am. 1968 Aug;48(4):787–798. doi: 10.1016/s0039-6109(16)38582-6. [DOI] [PubMed] [Google Scholar]
  19. Tracy O., Gordon A. M., Moran F., Love W. C., McKenzie P. Lincomycins in the treatment of bacteroides infections. Br Med J. 1972 Jan 29;1(5795):280–282. doi: 10.1136/bmj.1.5795.280. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES